Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
13.31
+0.45 (3.50%)
Apr 29, 2026, 11:57 AM EDT - Market open
Avalo Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 15.86 | 134.55 | 7.42 | 13.17 | 54.59 | Upgrade
|
| Short-Term Investments | 82.48 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 98.34 | 134.55 | 7.42 | 13.17 | 54.59 | Upgrade
|
| Cash Growth | -26.91% | 1714.51% | -43.71% | -75.87% | 188.52% | Upgrade
|
| Accounts Receivable | - | - | - | - | 1.06 | Upgrade
|
| Other Receivables | - | - | 0.14 | 1.92 | 3.74 | Upgrade
|
| Receivables | - | - | 0.14 | 1.92 | 4.8 | Upgrade
|
| Inventory | - | - | - | 0.02 | 0.04 | Upgrade
|
| Prepaid Expenses | 6.91 | 4.33 | 0.84 | 1.29 | 2.37 | Upgrade
|
| Restricted Cash | 0.04 | 0.02 | 0 | 0.02 | 0.05 | Upgrade
|
| Total Current Assets | 105.29 | 138.89 | 8.4 | 16.42 | 61.85 | Upgrade
|
| Property, Plant & Equipment | 0.46 | 1.21 | 1.97 | 2.41 | 2.7 | Upgrade
|
| Goodwill | 10.5 | 10.5 | 10.5 | 14.41 | 14.41 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 0.04 | Upgrade
|
| Other Long-Term Assets | 0.21 | 0.13 | 0.13 | 0.13 | 1.23 | Upgrade
|
| Total Assets | 116.46 | 150.73 | 20.99 | 33.37 | 80.21 | Upgrade
|
| Accounts Payable | 0.14 | 0.28 | 0.45 | 2.88 | 3.37 | Upgrade
|
| Accrued Expenses | 12.41 | 5.22 | 1.76 | 10.51 | 14.29 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 5.93 | - | Upgrade
|
| Current Portion of Leases | 0.39 | 0.57 | 0.54 | 0.53 | 0.49 | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.09 | - | Upgrade
|
| Other Current Liabilities | - | 0.89 | 1.87 | 2.17 | 1.74 | Upgrade
|
| Total Current Liabilities | 12.94 | 6.96 | 4.62 | 22.11 | 19.89 | Upgrade
|
| Long-Term Debt | - | - | - | 13.49 | 32.83 | Upgrade
|
| Long-Term Leases | 0.04 | 0.35 | 1.37 | 1.71 | 2.02 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.43 | 0.27 | 0.16 | 0.14 | 0.11 | Upgrade
|
| Other Long-Term Liabilities | 20 | 10.12 | 7.55 | 6.83 | 2.28 | Upgrade
|
| Total Liabilities | 33.41 | 17.7 | 13.69 | 44.28 | 57.13 | Upgrade
|
| Common Stock | 0.02 | 0.01 | 0 | - | 0.01 | Upgrade
|
| Additional Paid-In Capital | 531.49 | 503.29 | 342.44 | 292.91 | 285.24 | Upgrade
|
| Retained Earnings | -448.52 | -370.26 | -335.13 | -303.82 | -262.17 | Upgrade
|
| Comprehensive Income & Other | 0.07 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 83.05 | 133.03 | 7.3 | -10.92 | 23.08 | Upgrade
|
| Total Liabilities & Equity | 116.46 | 150.73 | 20.99 | 33.37 | 80.21 | Upgrade
|
| Total Debt | 0.43 | 0.92 | 1.9 | 21.66 | 35.34 | Upgrade
|
| Net Cash (Debt) | 97.91 | 133.63 | 5.51 | -8.49 | 19.25 | Upgrade
|
| Net Cash Growth | -26.73% | 2324.31% | - | - | 10.28% | Upgrade
|
| Net Cash Per Share | 7.30 | 17.83 | 19.85 | -216.49 | 531.87 | Upgrade
|
| Filing Date Shares Outstanding | 22.79 | 10.67 | 1.03 | 0.06 | 0.04 | Upgrade
|
| Total Common Shares Outstanding | 18.51 | 10.47 | 0.8 | 0.04 | 0.04 | Upgrade
|
| Working Capital | 92.35 | 131.93 | 3.78 | -5.7 | 41.96 | Upgrade
|
| Book Value Per Share | 4.49 | 12.70 | 9.11 | -277.78 | 589.35 | Upgrade
|
| Tangible Book Value | 72.55 | 122.53 | -3.2 | -25.32 | 8.64 | Upgrade
|
| Tangible Book Value Per Share | 3.92 | 11.70 | -3.99 | -644.47 | 220.48 | Upgrade
|
| Machinery | 0.14 | 0.28 | 0.28 | 0.34 | 0.24 | Upgrade
|
| Leasehold Improvements | 0.24 | 0.9 | 0.9 | 0.74 | 0.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.